Pharmacokinetics/Pharmacodynamics, Safety And Efficacy Of Crizanlizumab In Patients With Sickle Cell Disease Aged 12 To <18 Years: 2-Year Data From The Phase 2 Solace-Kids Study
Crizanlizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Pharmacokinetics/Pharmacodynamics, Safety And Efficacy Of Crizanlizumab In Patients With Sickle Cell Disease Aged 12 To <18 Years: 2-Year Data From The Phase 2 Solace-Kids Study ### Output: Crizanlizumab